Cargando…
Effects of acetyl-dl-leucine in patients with cerebellar ataxia: a case series
No existing medication has yet been shown to convincingly improve cerebellar ataxia. Therefore, the identification of new drugs for its symptomatic treatment is desirable. The objective of this case series was to evaluate the efficacy of treatment of cerebellar ataxia with the amino acid acetyl-dl-l...
Autores principales: | Strupp, Michael, Teufel, Julian, Habs, Maximilian, Feuerecker, Regina, Muth, Carolin, van de Warrenburg, Bart P., Klopstock, Thomas, Feil, Katharina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824630/ https://www.ncbi.nlm.nih.gov/pubmed/23835634 http://dx.doi.org/10.1007/s00415-013-7016-x |
Ejemplares similares
-
Acetyl-DL-leucine improves gait variability in patients with cerebellar ataxia—a case series
por: Schniepp, Roman, et al.
Publicado: (2016) -
Acetyl-dl-leucine in cerebellar ataxia ([(18)F]-FDG-PET study): how does a cerebellar disorder influence cortical sensorimotor networks?
por: Becker-Bense, Sandra, et al.
Publicado: (2022) -
Safety and Efficacy of Acetyl-DL-Leucine in Certain Types of Cerebellar Ataxia: The ALCAT Randomized Clinical Crossover Trial
por: Feil, Katharina, et al.
Publicado: (2021) -
Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial
por: Feil, Katharina, et al.
Publicado: (2017) -
Aminopyridines and Acetyl-DL-leucine: New Therapies in Cerebellar Disorders
por: Kalla, Roger, et al.
Publicado: (2019)